Serum levels of carboxy-terminal propeptide of human type I procollagen are an indicator for the progression of diabetic nephropathy in patients with Type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 48, Issue 1, 2000, Pages 23-28

  Inukai, T ^a   Fujiwara, Y ^a   Tayama, K ^a   Aso, Y ^a   Takemura, Y ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Osteocalcin; Type 2 diabetes; Type I procollagen

Indexed keywords

ALBUMIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; M PROTEIN; OSTEOCALCIN; PROCOLLAGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; RADIOIMMUNOASSAY; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0034001748     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00137-0     Document Type: Article

References (20)

1. Aso Y., Fujiwara Y., Tayama K., Ogino K., Inukai T., Takemura Y. Serum concentrations of type IV collagen but not laminin are elevated in proportion to the severity of diabetic retinopathy in diabetic patients without nephropathy. Diabetes Res. 32:1997;87-99.
2. Burgeson R.E. New collagens new concepts. Ann. Rev. Cell. Biol. 4:1988;551-577.
3. Ardaillou N., Bellon G., Nivez M.P., Rakotoarison S., Ardaillow R. Quantification of collagen synthesis by cultured human glomerular cells. Biochim. Biophys. Acta. 991:1989;445-452.
4. Melkko J., Niemi S., Risteli L., Risteli J. Radioimmunoassay of the carboxy-terminal propeptide of human type I procollagen. Clin. Chem. 36:1990;1328-1332.
5. Simon L.S., Krane S.M., Wortman P.D., Krane I.M., Kovitz K.L. Serum levels of type I and III procollagen fragments in Paget's disease of bone. J. Clin. Endocrinol. Metab. 58:1984;110-120.
6. Hasling C., Eriksen E.F., Melkko J., Risteli L., Charles P., Mosekilde L., Risteli J. Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis. J. Bone Miner. Res. 6:1991;1295-1300.
7. Bouillon R., Vanderschueren D., Van Herc K.E. Homologous radioimmunoassay of human osteocalcin. Clin. Chem. 38:1992;2055-2060.
8. Feldt-Rasmussen B., Dinesen B., Decker M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand. J. Clin. Lab. Invest. 45:1985;539-544.
9. Prockop D.J., Kivirikko K.I., Tuderman L., Guzman N.A. The biosynthesis of collagen and its disorders. N. Engl. J. Med. 301:1979;77-83.
10. Scheinmann J.I., Brown D.M., Michael A.F. Collagen synthesis by human glomerular cells in culture. Biochim. Biophys. Acta. 542:1978;128-136.
11. Killen P.D., Striker G.E. Human glomerular visceral epithelial cells synthesize a basal lamina collagen in vitro. Proc. Natl. Acad. Sci. U.S.A. 76:1979;3518-3522.
12. Taubman M.B., Goldberg B., Sherr C.J. Radioimmunoassay for human procollagen. Science. 186:1974;1115-1117.
13. Inukai T., Fujiwara Y., Tayama K., Aso Y., Takemura Y. Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 33:1996;99-104.
14. Hasslacher C.H., Reicherbacher R., Gechter F., Timple R. Glomerular basement membrane synthesis and serum concentration of type IV collagen in streptozotocin-diabetic rats. Diabetologia. 26:1984;150-154.
15. Haralson M.A., Jacobson H.R., Hoover R.L. Collagen polymorphism in cultured rat kidney mesangial cells. Lab. Invest. 57:1987;513-523.
16. Parfitt A.M., Simon L.S., Villanueva A.R., Krane S.M. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen bio-synthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J. Bone Miner. Res. 2:1987;427-436.
17. Hassager C., Jensen L.T., Johansen J.S., Riis B.J., Melkko J., Podenphant J., Risteli L., Christiansen C., Risteli J. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism. 40:1991;205-208.
18. Trivedi P., Risteli J., Risteli L., Hindmarsh P.C., Brook C.G.D., Mowat A.P. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr. Res. 30:1991;276-280.
19. 3 increases synthesis of vitamin K-dependent bone protein by osteosarcoma cells. J. Biol. Chem. 255:1980;11660-11663.
20. 3 and osteocalcin in patients with early diabetic nephropathy. Diabetes Res. Clin. Pract. 38:1997;53-59.